| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |